Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Original research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties.

Ballazhi L, Imeri F, Jashari A, Popovski E, Stojković G, Dimovski AJ, Mikhova B, Mladenovska K.

Acta Pharm. 2017 Mar 1;67(1):35-52. doi: 10.1515/acph-2017-0006.

PMID:
28231049
2.

Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases.

Ballazhi L, Popovski E, Jashari A, Imeri F, Ibrahimi I, Mikhova B, Mladenovska K.

Acta Pharm. 2015 Mar;65(1):53-63. doi: 10.1515/acph-2015-0002.

PMID:
25781704
3.

Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.

Jashari A, Imeri F, Ballazhi L, Shabani A, Mikhova B, Dräger G, Popovski E, Huwiler A.

Bioorg Med Chem. 2014 May 1;22(9):2655-61. doi: 10.1016/j.bmc.2014.03.026. Epub 2014 Mar 24.

PMID:
24721833
4.

3-[2-(5-tert-Butyl-1,2-oxazol-3-yl)hydrazinyl-idene]chroman-2,4-dione.

Jashari A, Popovski E, Mikhova B, Nikolova RP, Shivachev BL.

Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):o258. doi: 10.1107/S1600536813000858. Epub 2013 Jan 19.

Supplemental Content

Loading ...
Support Center